Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Apple and medical device company Masimo are currently embroiled in multiple legal battles, headlined by the ongoing fight over the Apple Watch’s blood oxygen sensor. In a separate case ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm ...

The litigation in Delaware became more complex when Masimo launched its W1 consumer watch in January 2022. Later, it was shown to replicate the core design elements of the Apple Watch, including a ...